145 related articles for article (PubMed ID: 7462631)
1. Agglutination of complement-coated erythrocytes by serum amyloid P-component.
Hutchcraft CL; Gewurz H; Hansen B; Dyck RF; Pepys MB
J Immunol; 1981 Mar; 126(3):1217-9. PubMed ID: 7462631
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and the acute phase response.
Gewurz H; Mold C; Siegel J; Fiedel B
Adv Intern Med; 1982; 27():345-72. PubMed ID: 7041546
[TBL] [Abstract][Full Text] [Related]
3. Binding of serum amyloid P-component (SAP) by amyloid fibrils.
Pepys MB; Dyck RF; de Beer FC; Skinner M; Cohen AS
Clin Exp Immunol; 1979 Nov; 38(2):284-93. PubMed ID: 118839
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat.
de Beer FC; Baltz ML; Munn EA; Feinstein A; Taylor J; Bruton C; Clamp JR; Pepys MB
Immunology; 1982 Jan; 45(1):55-70. PubMed ID: 7056568
[TBL] [Abstract][Full Text] [Related]
5. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.
García de Frutos P; Dahlbäck B
J Immunol; 1994 Mar; 152(5):2430-7. PubMed ID: 8133054
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid P component forms a stable complex with human C5b6.
Barbashov SF; Wang C; Nicholson-Weller A
J Immunol; 1997 Apr; 158(8):3830-5. PubMed ID: 9103450
[TBL] [Abstract][Full Text] [Related]
7. Binding of human serum amyloid P-component to phosphocholine.
Christner RB; Mortensen RF
Arch Biochem Biophys; 1994 Nov; 314(2):337-43. PubMed ID: 7979374
[TBL] [Abstract][Full Text] [Related]
8. Jeltraxin, a frog egg jelly glycoprotein, has calcium-dependent lectin properties and is related to human serum pentraxins CRP and SAP.
Peavy TR; Hernandez C; Carroll EJ
Biochemistry; 2003 Nov; 42(44):12761-9. PubMed ID: 14596590
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of platelet activation by the amyloid P-component of serum.
Fiedel BA; Ku CS; Izzi JM; Gewurz H
J Immunol; 1983 Sep; 131(3):1416-9. PubMed ID: 6886420
[TBL] [Abstract][Full Text] [Related]
10. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
Maeda S
Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of rat C4b binding protein alpha- and beta-chains: structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins.
Hillarp A; Wiklund H; Thern A; Dahlbäck B
J Immunol; 1997 Feb; 158(3):1315-23. PubMed ID: 9013975
[TBL] [Abstract][Full Text] [Related]
12. Nephelometric measurement of human serum amyloid P component (SAP).
Gertz MA; Skinner M; Cohen AS; Kyle RA
J Lab Clin Med; 1983 Nov; 102(5):773-8. PubMed ID: 6631169
[TBL] [Abstract][Full Text] [Related]
13. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
Ying SC; Gewurz AT; Jiang H; Gewurz H
J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
[TBL] [Abstract][Full Text] [Related]
14. Human serum amyloid P component binds to peripheral blood monocytes.
Macdonald SL; Kilpatrick DC
Scand J Immunol; 2006 Jul; 64(1):48-52. PubMed ID: 16784490
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.
Hohenester E; Hutchinson WL; Pepys MB; Wood SP
J Mol Biol; 1997 Jun; 269(4):570-8. PubMed ID: 9217261
[TBL] [Abstract][Full Text] [Related]
17. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.
Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB
Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an extended interacting surface between beta-amyloid and serum amyloid P component.
Likó I; Mák M; Klement E; Hunyadi-Gulyás E; Pázmány T; Medzihradszky KF; Urbányi Z
Neurosci Lett; 2007 Jan; 412(1):51-5. PubMed ID: 17141957
[TBL] [Abstract][Full Text] [Related]
19. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
Pepys MB; Herbert J; Hutchinson WL; Tennent GA; Lachmann HJ; Gallimore JR; Lovat LB; Bartfai T; Alanine A; Hertel C; Hoffmann T; Jakob-Roetne R; Norcross RD; Kemp JA; Yamamura K; Suzuki M; Taylor GW; Murray S; Thompson D; Purvis A; Kolstoe S; Wood SP; Hawkins PN
Nature; 2002 May; 417(6886):254-9. PubMed ID: 12015594
[TBL] [Abstract][Full Text] [Related]
20. Studies of the structure and binding properties of hamster female protein.
Tennent GA; Baltz ML; Osborn GD; Butler PJ; Noble GE; Hawkins PN; Pepys MB
Immunology; 1993 Dec; 80(4):645-51. PubMed ID: 7508422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
